Caladrius Biosciences, Inc. Announces Second Quarter 2015 Financial Results and Provides Corporate Update
Revenues up 31% from 2Q 2014 and Company Sets Future Direction for its Ischemic Repair Program New York, August 6, 2015 - Caladrius Biosciences, Inc. (Nasdaq:CLBS) ('Caladrius' or the 'Company'), a company ...